Member Spotlight

Mark Rapaport University of Utah announces new CEO to head Huntsman Mental Health Institute  November 2020


Mark Rapaport Inaugural CEO announced for Utah’s Huntsman Mental Health Institute  November 2020


Bashkim Kadriu, MD; Zhi-De Deng, PhD; Christoph Kraus, MD, PhD; Ioline D. Henter, MA; Sarah H. Lisanby, MD; and Carlos A. Zarate, Jr, MD Not So Fast: Recent Successes and Failures in Treating Depression May 2020


Daniel Guinart, MD; and Christoph U. Correll, MD Antipsychotic Polypharmacy in Schizophrenia: Why Not? April 2020


Sara Carlini, MD; and Kristina Deligiannidis, MD Evidence-Based Treatment of Premenstrual Dysphoric Disorder: A Concise Review February 2020


Luca Pani, MD Setting the Stage: Digital Medicine and the Brain, Setting the Stage: Digital Medicine and the Brain Slides October 2019


Leslie Citrome, MD, MPH Transdermal Patches in Psychiatry: Interview with Dr. Leslie Citrome August 2019


Manish Kumar Jha, MD Anti-Inflammatory Treatments for Major Depressive Disorder: What’s on the Horizon? June 2019


Rajiv Radhakrishnan, MD; Mohini Ranganathan, MD; and Deepak Cyril D’Souza MD  Medical Marijuana: What Physicians Need to Know May 2019


Justin Faden, DO Treatment Resistant Schizophrenia, A Brief Overview of Treatment OptionsMay 2019


Teddy J. Akiki, MD, and Chadi G. Abdallah, MD Are There Effective Psychopharmacologic Treatments for PTSD? December 2018


S. Nassir Ghaemi, MD, MPH; Ira D. Glick, MD,*; and James M. Ellison, MD, MPH A Commentary on Existential Psychopharmacologic Clinical Practice: Advocating a Humanistic Approach to the “Med Check” April 2018


Michael E. Thase, MD A Note from the ASCP President


Trisha Suppes, MD, PhD, Depression With Mixed Features in Major Depressive Disorder: A New Diagnosis or There All Along? January 2018


Ahmed N. Hassan, MD, FRCPC, MPH, Patients With Alcohol Use Disorder Co-Occurring With Depression and Anxiety Symptoms: Diagnostic and Treatment Initiation Recommendations January 2018


Amanda Tinkelman, MD, Emily A. Hill, MD, Kristina M. Deligiannidis, MD, Management of New Onset Psychosis in the Postpartum Period November 2017


Joseph F. Goldberg, MD, Do You Order Pharmacogenetic Testing? Why? August 2017


Jose M. Rubio, MD, & Christoph U. Correll, MD, Duration and Relevance of Untreated Psychiatric Disorders, 2: Nonpsychotic Psychiatric Disorders and Substance Use Disorders. May 2017


Jose M. Rubio, MD, & Christoph U. Correll, MD, Duration and Relevance of Untreated Psychiatric Disorders, 1: Psychotic Disorders. April 2017


Arif Khan, MD, High Risk of Death Participating in Drug Trials with a Psychiatric Illness. August 2013